ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

Cancer Treatment Modalities

An Interdisciplinary Approach

Nima Rezaei

$490.95   $392.41

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer Nature Switzerland AG
20 August 2025
The “Cancer Treatment Modalities: An Interdisciplinary Approach” is the twenty fourth volume of the “Interdisciplinary Cancer Research” series, publishes comprehensive volume on cancer treatment. The volume starts with a chapter on an interdisciplinary approach to biomarker discovery for cancer treatment, followed by other chapters on multidisciplinary approach in cancer management; and the interplay between inflammation and cancer progression. Cancer stem cells and mesenchymal stem cells are discussed in cancer therapy in other chapters. RNA epigenetics in cancer diagnosis and treatment as well as different aspects of telomerase inhibitors in cancer treatment are the subjected of subsequent chapters. Then bioimplants for the reconstructive surgery and the interplay of ferroptosis and cuproptosis in cancer are discussed. Liquid biopsy and cancer and mitochondrial transplantation are the subjects of other chapters. Microbial-based therapies in cancer treatment and bacteria-based approach to cancer therapy are the subjects of final chapters of this volume. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for those who wish to have an update on cancer treatment.
Edited by:  
Imprint:   Springer Nature Switzerland AG
Country of Publication:   Switzerland
Dimensions:   Height: 235mm,  Width: 155mm, 
ISBN:   9783032038654
ISBN 10:   3032038650
Series:   Interdisciplinary Cancer Research
Pages:   678
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Hardback
Publisher's Status:   Active

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,700 scientific papers in the international journals.

See Also